Delayed Denosumab Injections and Fracture Risk Among Patients With Osteoporosis: A Population-Based Cohort Study

Oct-20

Musculoskeletal Pharmacoepidemiology Rheumatology

AUTHORS : Dr Daniel H. Solomon, MD, MPH, Division of Rheumatology, Brigham and Women’s Hospital, 60 Fenwood Road, Boston, MA 02115 – Email: dsolomon@bwh.harvard.edu – Profile: https://researchfaculty.brighamandwomens.org/BRIProfile.aspx?id=2435 OR Peifu Tang, MD, PhD, National Clinical Research Center for Orthopedics, Sports Medicine & Rehabilitation, General Hospital of Chinese PLA, 28 Fuxing Road, Beijing 100853, China – Email, pftang301@126.com) OR Guanghua Lei, MD, PhD, Department of Orthopaedics, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha 410008, China – Email: lei_guanghua@csu.edu.cn – Profile: https://www.xiangya.com.cn/english/ezj_info.aspx?id=134&chn=3420

JOURNAL : Annals of Internal Medicine

REFERENCE: 173(7):516-526

DOI : 10.7326/M20-0882

Delayed Denosumab Injections and Fracture Risk Among Patients With Osteoporosis: A Population-Based Cohort Study

More publications

Characteristics, risk factors and clinical impact of penicillin and other antibiotic allergies in adults in the UK General Practice: a population-based cohort study

Glucose Lowering through Weight management (GLoW): a randomised controlled trial of the clinical and cost effectiveness of a diabetes education and behavioural weight management programme vs a diabetes education programme in adults with a recent diagnosis of type 2 diabetes

Target Serum Urate Achievement and Chronic Kidney Disease Progression in Patients With Gout and Kidney Disease